Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million
12/05/2026 13:00
May 12 (Reuters) - Kalaris Therapeutics Inc Q1 operating expenses USD 11.833 million. Q1 net income USD -10.856 million vs. IBES estimate USD -11.7 million
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million